drugset / Trial / NCT01042574
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, open label protocol evaluating the use of Cleviprex to rapidly control hypertension in patients who present with intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH), and that require ICP monitoring via ventriculostomy (External Ventricular Drain or EVD).
Timeline
- Start
- 2010-05
- Primary completion
- 2010-12-31
- Completion
- 2010-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clevidipine | Small molecule | 2 mg | Intravenous |